Glauben, Rainer <br/><br/>
HDAC inhibitors in models of inflammation-related tumorigenesis.  [electronic resource] 

 -  Cancer letters  Aug 2009 
 - 154-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1872-7980 
<br/><br/><label>Standard No.: </label>10.1016/j.canlet.2008.11.019  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetylation<br/>Animals<br/>Anti-Inflammatory Agents--therapeutic use<br/>Anticarcinogenic Agents--therapeutic use<br/>CD4-Positive T-Lymphocytes--immunology<br/>Cell Transformation, Neoplastic--drug effects<br/>Colitis--drug therapy<br/>Colonic Neoplasms--immunology<br/>Histone Deacetylase Inhibitors<br/>Histone Deacetylases--metabolism<br/>Humans<br/>Inflammation--drug therapy<br/>NF-kappa B--metabolism<br/>Neoplasms--drug therapy